13 news items
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
BMY
23 May 24
Three-year follow-up data from the Phase 3 RELATIVITY-047 study demonstrating sustained responses
New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
BMY
16 May 24
that provides sustained relief from this chronic disease, allowing patients to prioritize other aspects of their daily lives. These findings further reinforce
Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
BMY
15 May 24
Breyanzi provided sustained clinical benefit
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
BMY
25 Apr 24
better reflect patient populations;
Sustained workforce representation and increased community engagement
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
ATNM
AZN
BMY
18 Apr 24
and strategic industry movements.
Morgan Stanley predicts sustained outperformance for biotech stocks, particularly
h560eqmle4q3ks 7thh73tn2lmx3qc
BMY
2 Apr 24
is committed to advancing sustainability."
In 2023, BMS conducted a global
i5d0hbawjw5kdbkj2gpikk46wxt mjsrfdu410xrhk93
BMY
GERN
15 Mar 24
.
A sustained increase in mean hemoglobin levels in imetelstat-treated patients was observed over time compared to placebo patients
u333bvdf
BMY
29 Feb 24
Sustained efficacy was confirmed with an annualized
s5fp8obaj 1f4awrrr3ca9lmv5k8c
BMY
SYY
TPR
29 Feb 24
to drive sustainable growth and shareholder value
rqbxihaz6myvyodjdogt23 ykm4zd9j
BMY
IMCR
28 Feb 24
to a revenue-generating, sustainable company," said Bahija Jallal, CEO of Immunocore. "We look forward to the next 5 years, when we
- Prev
- 1
- Next